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Abstract
Background: The potential of cereals with high antioxidant capacity for reducing oxidative stress and
inflammation in obesity is unknown. This study investigated the impact of wheat bran, barley or a control diet (a-
cellulose) on the development of oxidative stress and inflammation in lean and obese Zucker rats.
Methods: Seven wk old, lean and obese male Zucker rats (n = 8/group) were fed diets that contained wheat bran,
barley or a-cellulose (control). After 3 months on these diets, systolic blood pressure was measured and plasma
was analysed for glucose, insulin, lipids, oxygen radical absorbance capacity (ORAC), malondialdehyde, glutathione
peroxidase and adipokine concentration (leptin, adiponectin, interleukin (IL)-1b, IL-6, TNFa, plasminogen activator
inhibitor (PAI)-1, monocyte chemotactic protein (MCP)-1). Adipokine secretion rates from visceral and subcutaneous
adipose tissue explants were also determined.
Results: Obese rats had higher body weight, systolic blood pressure and fasting blood lipids, glucose, insulin,
leptin and IL-1b in comparison to lean rats, and these measures were not reduced by consumption of wheat bran
or barley based diets. Serum ORAC tended to be higher in obese rats fed wheat bran and barley in comparison to
control (p = 0.06). Obese rats had higher plasma malondialdehyde (p < 0.01) and lower plasma glutathione
peroxidase concentration (p < 0.01) but these levels were not affected by diet type. PAI-1 was elevated in the
plasma of obese rats, and the wheat bran diet in comparison to the control group reduced PAI-1 to levels seen in
the lean rats (p < 0.05). These changes in circulating PAI-1 levels could not be explained by PAI-1 secretion rates
from visceral or subcutaneous adipose tissue.
Conclusions: A 3-month dietary intervention was sufficient for Zucker obese rats to develop oxidative stress and
systemic inflammation. Cereal-based diets with moderate and high antioxidant capacity elicited modest
improvements in indices of oxidative stress and inflammation.
Background
Oxidative stress commonly develops in obesity and has
been identified as the unifying mechanism underlying
the development of obesity-related co-morbidities. In
obesity, a variety of factors contribute to oxidative stress
including; hyperglycemia, hyperleptinemia, increased tis-
sue lipid levels, inadequate antioxidant defence,
increased rates of free radical formation from enzymatic
sources within the endothelium and chronic systemic
inflammation [1]. Effective treatments for reducing
oxidative stress levels in obese humans include surgical
i n t e r v e n t i o n sa sw e l la sl i f estyle modification such as
energy restriction and exercise to promote weight loss
[1]. In addition, antioxidant rich diets can reduce oxida-
tive stress and inflammatory responses independent of
weight loss [2]. Consumption of fruits, vegetables and
red wine has been shown to increase serum antioxidant
activity in vivo in the young and elderly [3-5]. In addi-
tion, wholegrains and dietary fibre rich in phenolics and
other compounds (b-carotene, iron, manganese, querce-
tin, tocopherol, zinc and ascorbic acid), also reduce oxi-
dative stress in people with metabolic syndrome [6].
Studies in healthy rodents have shown that phenolic-
rich cereals lowered oxidised lipids in blood, liver and
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enzymes in blood including glutathione peroxidase and
superoxide dismutase activity [7,8]. However, it is not
known whether phenolic-rich cereal based diets reduce
oxidative stress in animals with metabolic syndrome.
Diets high in fibre, including cereal fibres are asso-
ciated with a reduction in inflammatory markers [9,10].
There are a variety of possible mechanisms for this asso-
ciation. As weight loss intervention studies in obese sub-
jects improve the low grade inflammation of
subcutaneous and visceral adipose tissue depots [11-13],
dietary fibre intervention studies that reduce weight may
indirectly reduce inflammation [14]. A psyllium fibre
intervention in obese Zucker rats, reduced body weight
gain and subsequently reduced circulating tumor necro-
sis factor (TNF)-a levels [15]. Dietary fibre also reduces
markers of inflammation independent of weight loss.
During the postprandial response to a meal, cereal fibre
elicits a lower rise in plasma interleukin (IL)-6 in com-
parison to a potato meal [16]. This lower inflammatory
response has been attributed to the low glycemic impact
of cereal fibre, which if consumed over the long term
could contribute to a lower inflammatory status. In
addition, cereals high in phenolic compounds may also
directly reduce lipid accumulation in adipocytes and
pre-adipocytes [17] and have been shown to reduce
inflammation in a variety of animal models [18-20].
Zucker obese rats are the most widely used animal
model of obesity as they develop dyslipidemia, mild glu-
cose intolerance, hyperinsulinemia, hypertension and
low-grade inflammation, manifestations similar to those
that define human metabolic syndrome [21,22]. Addi-
tionally Zucker obese rats develop oxidative stress. Oxi-
dised lipids are elevated in serum, urine and liver by 14
weeks of age [23-25] and plasma antioxidant defence
mechanisms such as glutathione peroxidase are compro-
mised [24,26]. Accordingly the Zucker rat is an appro-
priate model for studying the effect of dietary
components on oxidative stress associated with meta-
bolic disturbances in overweight and obese humans.
This study aimed to compare the effect of diets con-
taining wheat bran (a commonly consumed fibre fraction
in Australia) and a wholegrain barley with high in vitro
antioxidant capacity on markers of oxidative stress and
inflammation in lean and obese Zucker rats. It was
hypothesised that the cereal diets would increase antioxi-
dant capacity and reduce oxidative stress in obese rats, as
well as reduce inflammation in the vascular system and
adipose tissue in comparison to a low-antioxidant diet.
Methods
Animal and feeding procedures
Male six week old Zucker rats, obese fa/fa (n = 24) and
lean Fa/? (n = 24) were obtained from the Flinders
University animal house, Bedford Park, South Australia.
Rats were housed in wire bottomed cages in a room
with controlled heating and lighting (23°C with a 12-h
light/dark cycle) and had free access to food and water.
After arrival, the rats were adapted to a non-purified
commercial diet for one week. They were allocated ran-
domly to three groups (n = 8 per group) and fed one of
three diets (Table 1) for twelve weeks.
The diets, based on AIN-93G formulation, contained a-
cellulose, wheat bran or barley flour which were added to
the diet to provide 4.5% neutral non-starch polysaccharide
(NNSP) (Table 1). Wheat bran was a commercially avail-
able product suitable for human consumption and a con-
ventional barley, cv Torrens, was used (supplied by
Amanda Box, University of Adelaide). The wheat bran and
barley were milled to a particle size of 2-3 mm by the
Bread Research Institute, Victoria. Macronutrient compo-
sition of the cereals was determined as described pre-
viously [27,28] using Official Methods of Analysis of
AOAC International [29] (Table 2). For NNSP, a modified
version of the gas chromatography method of Theander et
al [30] (AOAC method 994.13) was used; the method
employed a scaled-down procedure using a 2-h hydrolysis
with dilute (1 mol/L) sulphuric acid followed by centrifu-
gation (2000 g, 15 min) to obtain the insoluble NNSP, and
a further hydrolysis using 2 mol/L trifluoroacetic acid for
the soluble NNSP. The vitamin mix was based on AIN-76
[31] with 50 mg a-tocopherol provided per kg of diet
which is 33% of the recommended amount. The antioxi-
dant capacity of the diets as determined by the oxygen
radical absorbance capacity (ORAC) assay were; Control,
1.1 ± 0.2, wheat bran 7.1 ± 0.1, barley 10.3 ± 0.1 μmol
Trolox equivalents/g (Table 2). Food intake was calculated
daily (food remaining subtracted from the amount of food
provided) for each cage of four animals throughout the
twelve weeks feeding study.
Table 1 Diet composition1
Control Wheat bran g/kg Barley
a-cellulose
wheat bran
barley
45 164.8 608.1
cornstarch 534.5 447.2 55.3
casein 200 174.1 130.1
sucrose 100 100 100
sunflower seed oil 70 70 70
mineral mix
2 35 35 35
vitamin mix
3 10 10 10
cystine 3 3 3
choline 2.5 2.5 2.5
1 All diets contain 4.5% neutral non-starch polysaccharides and the wheat
bran and barley were added as a flour of similar particle size (2-3 mm).
2 mineral mix AIN-93G
3 vitamin mix AIN-76, with only 33% of a-tocopherol was provided.
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overnight (15 h) and then anesthetised with sodium
pentobarbital and the femeral artery canulated to enable
measurements of blood pressure and heart rate (Biopac
data acquisition system, Santa Barbara, CA). Blood was
collected from the abdominal aorta, processed to obtain
serum and EDTA plasma and stored at -80°C until ana-
lysed. The major organs and adipose tissue, including
mesenteric, epididymal, retroperitoneal and inguinal fat
were removed and weighed. All procedures involving
animals were approved by the Commonwealth Scientific
and Industrial Research Organisation Food and Nutri-
tional Sciences Animal Ethics Committee.
Blood analyses
Plasma triglyceride and total cholesterol concentrations
were measured in one run on a BM/Hitachi 902 Auto-
matic Analyzer with the use of standard Roche enzy-
matic kits (Roche Diagnostics Co, Indianapolis, IN).
Plasma glucose was measured by YSI 2700 Select Bioa-
nalyser (Yellow Springs, OH), using the 2747 Dual Cali-
bration Standard. The concentrations of insulin, leptin,
adiponectin, IL-1b, IL-6, monocyte chemotactic protein
(MCP-1), plasminogen activator inhibitor (PAI)-1 and
TNF-a in the plasma was determined using a Rat Adi-
pokine multiplex kit (Millipore, St. Charles, MO, USA)
according to manufacturer’s instructions. The analyses
were conducted in a single run and the mean intra-
assay coefficient of variation (CVs) ranged from 3-8%.
Multianalyte profiling was performed on the LiquiChip
200 Workstation (Qiagen, Melbourne, Australia) and
fluorescence data were analysed by using the LiquiChip
Analyzer Software (version 1.0.5, Qiagen, Melbourne,
Victoria, Australia).
Plasma ORAC was determined according to a modi-
fied method of Cao et al. [32], which has been described
in detail elsewhere [33]. Briefly, the serum and serum
non-protein fractions were extracted by two methods.
The ORACpca (perchloric acid) was measured using 1
part serum to 1 part perchloric acid which only
extracted water-soluble antioxidants. Following centrifu-
gation, the supernatant was diluted using phosphate buf-
fered saline (1:20). The ORACac (acetone) was measured
using one part serum to nine parts acetone which
extracted both lipid and water soluble antioxidants. Fol-
lowing centrifugation, the supernatant was diluted using
7% randomly methylated b-cyclodextrin diluted in one
part acetone to one part water (final dilution of serum
1:100). Each serum extract (20 μL), in duplicate, reacted
with 25 μLo f3m Mo f2 , 2 ’-azobis(2-amidinopropane)
4-hydrochloride at 37°C, and kinetic reads were per-
formed at 60 sec intervals for 50 cycles at an excitation
wavelength of 598 nm and an emission wavelength of
615 nm (EnVision, Perkin Elmer, Waltham, Massachu-
setts). The absorbance readings were plotted against
time and the area under the curves was determined.
T r o l o xw a su s e da sar e f e r e n c ea n t i o x i d a n ta n das t a n -
dard curve was obtained to calculate the ORAC values
for each sample. One ORAC unit was defined as the net
protection area provided by 1 μM final concentration of
Trolox.
Plasma glutathione peroxidase was analysed using a
commercial kit (Sigma, St Louis, Missouri). EDTA
plasma was diluted with glutathione peroxidase assay
buffer (1:4) and 20 μL was added, in duplicate, to a 96
well plate. Serial dilutions of a glutathione peroxidase
standard (Sigma, St Louis, Missouri) were included to
obtain a standard curve. Glutathione peroxidase assay
buffer (140 μL) was added to each well followed by 10
μL nicotinamide adenine dinucleotide phosphate
(NADPH) solution. The plate was transferred to an
EnVision plate reader (Perkin Elmer, Waltham, Massa-
chusetts). After 10 min incubation at 25°C, 20 μLt -
butyl hydroperoxide was added to each well and kinetic
reads were performed at 20 sec intervals for a period of
5 mins at a wavelength of 340 nm. The absorbance
readings were plotted against time and the slopes of the
linear part of the curves determined. The slope for the
blank wells (containing assay buffer, NADPH and t-
butyl hydroperoxide) was subtracted from the slope of
the lines for standards and plasma samples. The
adjusted slopes of the glutathione peroxidase standards
were used to generate a standard curve against which
the adjusted slopes of the plasma samples were plotted
to determine the glutathione peroxidase activity for each
sample. The Glutathione peroxidase concentration was
reported as U glutathione peroxidase/mL plasma where
1 U of glutathione peroxidase is defined as reducing
NADPH at a rate of 1 mmol/mL/min.
Malondialdehyde was measured in plasma samples by
high performance liquid chromatography. A 150 μl ali-
quot of MDA standard or plasma, in triplicate, was
Table 2 Proximate composition, total phenolics and antioxidant capacity of wheat bran and barley1
Fat Protein Total starch b-glucan Total dietary fibre Neutral non-starch polysaccharides Phenolics ORAC
1
g/100 g mg/100 g μmol Trolox/g
wheat bran 4.1 14.0 15.4 2.0 43.1 24.4 225 83.9
barley 2.5 10.1 64.8 3.0 12.1 6.9 173 33.4
1Oxygen radical antioxidant capacity, both lipid and water soluble components were assessed
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The MDA standard was generated from 1,1,3,3-tetra-
ethoxypropane (TEP) by hydrolysis when heated with
thiobarbituric acid (TBA) reagent during the assay (1
mole of TEP generates 1 mole of MDA) and a standard
curve (0.125 - 1.0 μM) was obtained by diluting the 20
μM TEP standard (stable at 4°C for up to 1 month) in
water. To precipitate proteins and release the MDA
bound to the amino groups of proteins and other amino
compounds [34], 75 μl of cold 1 M HClO4 was added to
the standard and plasma samples and the tubes were
mixed immediately. The tubes were centrifuged at
12,000 g for 3 minutes at 4°C and 150 μL of supernatant
transferred into 2 mL glass chromatography vials in a
rack on ice. 50 μL of 1 M NaOH was added to all vials
and vortex immediately. The fluorescent MDA-TBA
derivative was prepared by adding 800 μl TBA reagent
(0.25% TBA, 1.25 mM diethylenetriaminepentaacetic
acid in 2.5 M acetate buffer pH 3.5) and 10 μLo f5 %
butylatedhydroxytoluene in ethanol. Samples were
mixed, placed in a shaking water bath at 95°C for 60
minutes [35] and immediately cooled in ice water and
kept at 7°C prior to analysis by high performance liquid
chromatography which consisted of a LC1610 autosam-
pler, LC1150 quarternary pump and WinChrom soft-
ware (GBC Scientific Equipment Pty Ltd, Braeside,
Victoria, Australia). The fluorescence of MDA-TBA was
monitored with a Shimadzu RF-10A fluorescence detec-
tor (excitation 515 nm and emission: 553 nm). A 40 μL
sample was injected onto a Microsorb MV 5 μmC 1 8
reverse phase, 250 × 4.6 mm column (Varian Australia
Pty Ltd, Mulgrave, Victoria, Australia) and eluted under
isocratic conditions with a mobile phase consisting of
42:58 methanol/50 mM potassium phosphate buffer pH
5.8 at a flow rate of 1.0 mL/minute. A typical chromato-
gram of a plasma sample and standard are shown in
Figure 1.
Tissue explant experiments
Adipose tissue explants from inguinal (subcutaneous)
and peri-renal (visceral) adipose tissue were prepared
for tissue culture analysis following the method pre-
viously described [36]. The explants were cultured in a-
minimal essential medium for 24 h, refreshed, then col-
lected after another 24 h of incubation. The collected
media was then filter-sterilised and stored at -80°C until
use. The concentrations of adiponectin, IL-1b,I L - 6 ,
TNF-a, MCP-1 and PAI-1 (total) in the adipose tissue-
conditioned medium were determined using a Rat Adi-
pocyte Lincoplex Kit (Millipore, St. Charles, MO, USA)
according to manufacturer’s instructions. Multianalyte
profiling was performed on the LiquiChip 200 Worksta-
tion (Qiagen, Melbourne, Australia) and fluorescence
data were analysed by using the LiquiChip Analyzer
Software (version 1.0.5, Qiagen, Melbourne, Victoria,
Australia).
Statistical analyses
Data are presented as the arithmetic mean ± SEM for
each treatment group. The effect of diet type and rat
phenotype on growth rate was determined by a two-way
repeated measures analysis of variance (ANOVA); for all
variables two-way ANOVA was performed. Differences
between treatments were analysed by a Tukey’sp o s t -
hoc test. These analyses were performed using SPSS
A. 
B. 
Figure 1 Typical chromatograms of (A) a plasma sample and
(B) 1 μM malondialdehyde (MDA) standard.
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0.05 was taken as the criterion of significance.
Results
Food intake and body weight gain
Obese rats consumed 30% more food than lean rats
(obese; 33 ± 5, lean; 21 ± 3 g/d, p < 0.001), that contrib-
uted to a 43% higher body weight at the end of the
study (obese; 609 ± 10, lean; 426 ± 9 g, p < 0.0001).
Rats on the wheat bran diet in comparison to those fed
the barley diet had a lower weight gain (wheat bran; 25
± 0.8, barley; 29 ± 0.9 g/wk, p = 0.006) and final body
weight (wheat bran; 497 ± 12, barley; 542 ± 12 g, p =
0.034) (Table 3). The Control group did not differ from
the wheat bran or barley groups in mean weight gain or
final body weight (Table 3).
Cardiovascular measures
Obese rats had a slower heart rate (obese; 419 ± 9, lean;
462 ± 8 bpm, p < 0.001) and lower heart weight (obese;
0.20 ± 0.005, lean; 0.26 ± 0.005% of body weight, p <
0.0001) in comparison to lean rats. The obese rats fed
w i t ht h eb a r l e yd i e th a das i g n i f i c a n t l yl o w e rh e a r tr a t e
than the lean rats fed with the Control diet (p < 0.05).
Overall, cereal type did not affect heart rate or heart
weight. Systolic blood pressure was lower in lean rats
t h a no b e s er a t s( l e a n ;1 4 6±5 . 4 ,o b e s e ;1 6 6±6 . 0
mmHg, p < 0.05) but was unaffected by cereal type. Dia-
stolic blood pressure was not affected by the obese phe-
notype or cereal type.
Adipose tissue and organ weights
The visceral (mesenteric, epididymal and retroperito-
neal) and subcutaneous (inguinal) adipose tissue depots
were substantially heavier in the obese than lean rats
when normalised to body weight (p < 0.0001). Cereal
type did not affect adipose tissue weight (Table 3).
Liver weight was lower in lean rats in comparison to
obese rats (lean; 10.1 ± 0.4, obese; 18.6 ± 0.5 g, p <
0.0001). In the obese rats, the barley diet fed animals
had a lower liver weight than the Control diet fed ani-
mals (p < 0.05) (Table 3). There was no effect of diet
type on liver weight for lean animals (Table 3). Kidney
weights were higher in lean than obese rats (Table 3).
Serum and plasma metabolites, hormones and adipokines
Lean Zucker rats had lower fasting glucose (lean; 9.7 ±
0.36, obese; 13.1 ± 0.36 mmol/L, p < 0.0001), insulin
(lean; 3.9 ± 0.9, obese; 9.7 ± 0.8 ng/mL, p < 0.001), lep-
tin (lean; 9.6 ± 3.6, obese; 45.4 ± 3.3 μg/mL, p < 0.0001)
total cholesterol (lean; 2.2 ± 0.2, obese; 5.1 ± 0.2 mmol/
L, p < 0.0001), free fatty acids (lean; 0.6 ± 0.3, obese; 2.7
± 0.3 mmol/L) and triglycerides (lean; 0.16 ± 0.2, obese;
1.5 ± 0.2 mmol/L, p < 0.0001) than obese rats. Cereal
type did not affect glucose, insulin, leptin, total choles-
terol, free fatty acid or triglyceride concentration.
Lean rats had lower plasma IL-1b (lean; 112 ± 29,
obese; 230 ± 27 pg/mL, p < 0.01) and PAI-1 concentra-
tion (lean; 653 ± 88, obese; 913 ± 82 pg/mL, p < 0.05)
than obese rats. In the obese rats, the wheat bran diet in
comparison to the Control diet, reduced PAI-1 to simi-
lar levels as the lean rats (p < 0.05) (Figure 2). IL-6 was
unaffected by phenotype or cereal type and TNF-a was
not detected in any of the samples (levels were below
the detection limit 3.2 pg/mL).
Antioxidant and oxidised lipid
Obese rats had significantly higher ORACac than lean
rats (obese; 2.2 ± 0.2, lean: 1.0 ± 0.2 μmol Trolox eq/
mL, p < 0.0001) (Table 4). In obese rats, wheat bran and
Table 3 Effect of Control, wheat bran and barley based diets on weight gain, organ and tissue weights of lean and
obese Zucker rats
1
Lean Obese
Control Wheat bran Barley Control Wheat bran Barley SEM Phenotype Diet P * D
Final body weight (g) 420
a 420
a 438
a 612
b 574
b 646
b 16.9 0.0001 0.034 0.244
Weight gain (g/wk) 20.6
a 20.3
a 21.9
a 33.3
b 29.5
b 35.9
b 1.2 0.0001 0.006 0.121
Organ weights (g)
Liver 9.4
a 10.5
a 10.3
a 21.0
c 18.1
bc 16.7
b 0.77 0.0001 0.109 0.005
Heart 1.11 1.10 1.16 1.17 1.24 1.23 0.034 0.007 0.346 0.554
Kidney 1.1
a 1.1
a 1.2
ab 1.4
b 1.3
b 1.4
b 0.05 0.0001 0.349 0.591
Adipose tissue weights (%BW)
2 1.7
a 1.6
a 1.7
a 2.6
b 2.8
b 2.4
b 0.2 0.0001 0.757 0.437
Mesenteric 1.9
a 1.9
a 1.9
a 3.0
b 3.4
b 2.9
b 0.2 0.0001 0.398 0.470
Epididymal 2.2
a 2.2
a 2.0
a 5.9
b 5.5
b 5.3
b 0.4 0.0001 0.541 0.852
Retroperitoneal
Inguinal
3.2
a 3.3
a 2.9
a 17.6
b 17.9
b 16.4
b 1.5 0.0001 0.805 0.936
1A different letter in the same row denotes significant difference, P < 0.05. Data is presented as a mean and pooled SEM, n = 8.
2 %BW, data is expressed as a percentage of rat body weight
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the Control diet fed animals (Table 4, p = 0.064). Phe-
notype and diet type did not affect ORACpca plasma
levels (Table 4).
Obese rats had significantly lower plasma glutathione
peroxidase levels in comparison to lean rats (lean; 1108
± 30, obese; 953 ± 27 μmol/min/mL, p < 0.001). The
obese rats fed the wheat bran diet had higher glu-
tathione peroxidase levels than the Control diet-fed
obese rats (p < 0.05) (Table 4). There was no difference
in plasma glutathione peroxidase between the barley fed
animals and the other dietary treatment groups.
Obese rats had significantly higher malondialdehyde
levels in comparison to lean (obese; 1.0 ± 0.07, lean; 0.7
± 0.07 nmol/mL, p < 0.001) (Table 4). Diet type did not
affect plasma malondialdehyde levels.
Adipokine secretory rates from adipose tissue
The secretion of adipokines from the subcutaneous fat
of obese rats was higher for leptin (p < 0.001) and
monocyte chemoatractant protein-1 (MCP-1) (p < 0.01)
and a trend to lower adiponectin (p = 0.10) in compari-
son to lean rats (Figure 3). The secretion of adipokines
from the visceral fat of obese rats was lower for adipo-
nectin (p < 0.05), with no change in IL-6, leptin, MCP-1
and PAI-1 (Figure 3). Diet type did not affect adipokine
secretion levels from subcutaneous or visceral fat (data
not shown).
The secretion of leptin and MCP-1 from subcutaneous
(leptin; r = 0.453, p = 0.018, MCP-1; r = 0.447, p =
0.020) but not visceral fat correlated with their circulat-
ing levels in plasma. Plasma PAI-1 did not correlate
with PAI-1 levels from subcutaneous or visceral fat.
Subcutaneous fat secretion of MCP-1 was correlated
with plasma levels of insulin (r = 0.456, p = 0.017), lep-
tin (r = 0.524, p = 0.005), and PAI-1 (r = 0.480, p =
0.011).
Discussion
The purpose of this study was to investigate the impact
of wheat bran and barley on markers of oxidative stress
and inflammation in lean and obese Zucker rats. In
comparison to the Control diet, the wheat bran- and
barley-based diets tended to increase the antioxidant
capacity of the lipid-soluble antioxidants in the serum.
This was evident by the increased antioxidant capacity
of serum when extracted by acetone but not perchloric
acid. However, the increase in serum antioxidant capa-
city ORACac in wheat bran- and barley-fed obese rats
did not reduce the amount of oxidised lipids in the
plasma, as measured by malondialdehyde, or increase
glutathione peroxidase activity. In addition for the lean
rats, none of these markers of oxidative stress were
affected by the antioxidant capacity of the diet. This is
in contrast to a study where rats were fed a barley grain
based diet (similar phenolic acid concentration as the
current study) which showed that although plasma total
antioxidant status remained unchanged, a less specific
assay of oxidised lipids in serum, thiobarbituric acid
reactive substance, decreased and plasma glutathione
peroxidase activity increased [7]. As the analyses were
conducted on fasting animals in the current study, the
differences between studies could be due in-part to
whether or not the animals were fasted. In the fasted
state, oxidative stress caused by obesity may override
any antioxidant effects that could be achieved by circu-
lating cereal grain components including; phenolics,
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Figure 2 Effect of control, wheat bran and barley based diets
on serum plasminogen activator inhibitor-1 (PAI-1) in obese
Zucker rats. Values are expressed as means ± SEM, n = 8. A
significant difference between groups, p < 0.001 is denoted by (*).
Table 4 Effect of control, wheat bran and barley based diets on serum antioxidant capacity and plasma glutathione
peroxidase and malondialdehyde concentration 1
Lean Obese
Control Wheat bran Barley Control Wheat bran Barley SEM Phenotype Diet P * D
ORACpca (μmol Trolox eq/mL)
2 1.4 1.3 1.3 1.4 1.2 1.1 0.1 0.182 0.204 0.512
ORACac (μmol Trolox eq/mL)
2 0.8 1.0 1.1 1.3 2.4 2.8 0.4 0.0001 0.08 0.294
Glutathione peroxidase (μmol/min/ml) 1101 1174 1049 911 980 968 45 0.001 0.274 0.441
Malondialdehyde (nmol/mL) 0.7 0.7 0.7 0.8 1.1 1.0 0.05 0.006 0.472 0.476
1 Data is presented as a mean and pooled SEM, n = 8.
2 Oxygen radical antioxidant capacity assay analysis of serum extracted with perchloric acid (ORACpca) or serum was extracted with acetone (ORACac).
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acids. To further understand the antioxidant potential of
barley in vivo it would be important to examine the
changes in antioxidant status during the postprandial
and post-absorptive stages of digestion in both lean and
obese animals. Furthermore, barley cultivars vary in
antioxidant capacity. While the barley grain and wheat
bran used in the current study had a moderate to high
in vitro antioxidant capacity, other barley cultivars have
been shown to have up to a 2-fold greater antioxidant
capacity [37]. Therefore, greater antioxidant effects may
be observed if other barley cultivars are used.
In obesity there is an increase in pro-inflammatory
cytokine levels in adipose tissue and in the circulation
which contributes to oxidative stress. We determined
whether cereal-based diets modulate both inflammation
and oxidative stress. The wheat bran diet reduced PAI-1
concentration in the plasma but did not affect other adi-
pokine levels; leptin, IL-1b or IL-6. This change in PAI-
1 could not be explained by the secretion rates of PAI-1
from subcutaneous or visceral adipose tissue. It is likely
that an alternative site of PAI-1 synthesis, the liver, was
responsible for regulating circulating PAI-1 levels. Pre-
vious studies show that short chain fatty acids produced
from the fermentation of dietary fibre in the large intes-
tine inhibit the hepatic synthesis of coagulation factors
through inhibition of fatty acid release [38]. In addition,
association and cohort studies also show an inverse
association between high fibre diets and PAI-1 levels
[39-41]. Thus, differences in the fermentation of wheat
bran in comparison to barley and a-cellulose may have
contributed to the lower PAI-1 levels.
The barley diet had no effect on weight gain or adip-
osity in lean or obese Zucker rats when compared to
the Control diet, even though both diets contained sub-
stantial levels of non-starch polysaccharides (4.5%). This
is consistent with a study that fed obese Zucker rats an
oat bran concentrate-based diet that contained higher
levels of b-glucan (10%) [42] than the current study
(2%). However, in a different animal model of obesity
(diet-induced obese mice), a similar level of dietary b-
glucan as provided in the current study (2% b-glucan
from barley grain), showed a reduction in weight gain,
but not adipose tissue weight [43]. Furthermore, no
additional reductions in body weight gain or adiposity
were observed with a 4% b-glucan diet. Overall, this
suggests that barley and oats (rich in b-glucan) have
limited effects on reducing weight gain associated with a
genetic model of obesity. However, barley grains may
prevent the development of diet-induced obesity by
improving insulin sensitivity through altering glucose
and lipid metabolism [43]. In addition, other varieties of
barley that contain high levels of other types of dietary
Figure 3 Adipokine secretion rates from subcutaneous and
visceral fat depots in lean (□)a n do b e s e( ■) Zucker rats.T h e
concentration of adipokines A) adiponectin, B) leptin, C) MCP-1, D)
PAI-1 and E) IL-6 were measured in media that was incubated
with adipose tissue for 24 hrs. Values are expressed as means ±
SEM, n = 8. A significant difference between groups, p < 0.001 is
denoted by (*).
Belobrajdic et al. Nutrition & Metabolism 2011, 8:27
http://www.nutritionandmetabolism.com/content/8/1/27
Page 7 of 10fibre such as fructan and amylose may provide addi-
tional benefits to metabolic health but this deserves
further investigation.
In the current study wheat bran did not affect body
weight gain or adiposity in lean or obese Zucker rats.
Similarly, Neyrinck et al [44] showed that a 10% wheat
bran diet did not reduce body weight gain or adiposity
compared to a 10% cellulose diet in diet-induced obese
mice. The primary non-starch polysaccharide compo-
nent of wheat bran is arabinoxylan, which is a soluble
fibre that is rapidly fermented in the colon. Abarbinoxy-
lan improves lipid and glucose metabolism in humans
and rats [45-49], but did not reduce body weight or
adiposity when type 2 diabetic patients consumed the
fibre fraction for five weeks [50]. Therefore, the poten-
tial of wheat bran per se in improving metabolic health
seems limited.
As the wheat bran and barley grain diets did not
reduce adipose tissue weight gain it is likely that the
levels of phenolics in these cereals were not sufficient to
inhibit lipid accumulation. In vitro studies support the
direct effect of phenolics on inhibiting lipid accumula-
tion in adipocytes and pre-adipocytes [17]. In particular,
the phenolics rutin and o-coumaric acid have been
shown have the greatest effect on inhibiting adipogen-
esis in 3T3-L1 adipocytes [51] and these phenolics when
fed to rats, reduced peritoneal and epididymal adipose
tissue weights [52]. However, these rats were adminis-
tered with more than 2.5 fold greater levels of phenolics
than provided by the wheat bran or barley diets in the
current study.
Even though obese Zucker rats had lower heart rate
and weight, and higher systolic and pulse pressure than
lean rats, these measures were unaffected by diet type.
Son et al [53] reported that rats consuming barley-based
high fat diet had larger aortic lumen and thinner wall
thickness than rats consuming a rice-based diet, which
is suggestive of a reduction in the accumulation of lipid
and/or plaque in the cardiovascular system of these ani-
mals. They also showed that plasma triglyceride, total
and LDL cholesterol was reduced by the barley diet. As
the diets contained high levels of fat and cholesterol (20
g/100 g fat provided by soybean oil, beef tallow, lard
and corn oil, as well as 1 g/100 g cholesterol) compared
to the present study, this may explain why no effect of
barley or wheat bran on triglyceride or total cholesterol
was seen in the current study.
Conclusions
Obesity-induced changes in markers related to meta-
bolic syndrome in Zucker rats were similar in animals
fed with Control, wheat bran- or barley-based diets.
Wheat bran and barley showed modest changes in mea-
sures of oxidative stress in obese Zucker rats, but it is
not known whether cereal varieties with higher phenolic
levels would provide a greater reduction in oxidative
stress in these animals. In addition, the wheat bran diet
lowered plasma PAI-1 levels in obese rats to levels seen
in the lean rats. This reduction in PAI-1 was indepen-
dent of changes in secretion rates from adipose tissue,
thus the effect of a moderate antioxidant diet on the
regulation of PAI-1 at other sites such as the liver
should be investigated further.
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